EF1a-HA-KORD-IRES-mCitrine AAV (Serotype 9)

Adeno-associated virus (AAV) vectors have emerged as a powerful tool for gene delivery in a variety of research and therapeutic applications. Among the numerous serotypes, AAV type 9 (AAV9) is particularly well-known for its ability to efficiently transduce a variety of tissues, including muscle, liver, heart, and central nervous system, making it a versatile choice for in vivo studies. The EF1a-HA-KORD-IRES-mCitrine AAV (Serotype 9) represents an advanced genetic construct designed to facilitate the study and manipulation of specific biological pathways.

The unique coding region of this construct expresses HA-KORD, a designer receptor activated exclusively by designer drugs (DREADDs). KORD (kappa opioid receptor DREADD) is designed to be activated by the synthetic ligand salvinorin B, enabling precise control of cellular signaling pathways associated with the kappa opioid receptor. This feature is particularly useful for neuroscience research, as modulation of neuronal activity can provide insights into behavior, neurological diseases, and potential therapeutic interventions.

Linked to HA-KORD is an internal ribosome entry site (IRES), which promotes cap-independent translation of the downstream gene mCitrine. This fluorescent protein, derived from yellow fluorescent protein (YFP), is an important marker that allows researchers to visually track and quantify the expression of viral vectors in living cells and tissues. The bright fluorescence of mCitrine makes it more flexible and can be monitored and analyzed in real time by various imaging techniques.